Affiliation:
1. Department of Surgical Gastroenterology Asian Institute of Gastroenterology Hyderabad India
2. College of Medicine and Public Health Flinders University Bedford Park South Australia Australia
3. Division of Surgery and Peri‐Operative Medicine Flinders Medical Center 5042 Bedford Park, Adelaide South Australia Australia
Abstract
AbstractBackgroundMinimally‐invasive pancreatoduodenectomy (MIPD) is fraught with the risk of complication‐related deaths (LEOPARD‐2), a significant volume‐outcome relationship and a long learning curve. With rates of conversion for MIPD approaching 40%, the impact of these on overall patient outcomes, especially, when unplanned, are yet to be fully elucidated. This study aimed to compare peri‐operative outcomes of (unplanned) converted MIPD against both successfully completed MIPD and upfront open PD.MethodsA systematic review of major reference databases was undertaken. The primary outcome of interest was 30‐day mortality. Newcastle–Ottawa scale was used to judge the quality of the studies. Meta‐analysis was performed using pooled estimates, derived using random effects model.ResultsSix studies involving 20,267 patients were included in the review. Pooled analysis demonstrated (unplanned) converted MIPD were associated with an increased 30‐day (RR 2.83, CI 1.62‐ 4.93, p = 0.0002, I2 = 0%) and 90‐day (RR 1.81, CI 1.16‐ 2.82, p = 0.009, I2 = 28%) mortality and overall morbidity (RR 1.41, CI 1.09; 1.82, p = 0.0087, I2 = 82%) compared to successfully completed MIPD. Patients undergoing (unplanned) converted MIPD experienced significantly higher 30‐day mortality (RR 3.97, CI 2.07; 7.65, p < 0.0001,I2 = 0%), pancreatic fistula (RR 1.65, CI 1.22‐ 2.23, p = 0.001, I2 = 0%) and re‐exploration rates (RR 1.96, CI 1.17‐ 3.28,p = 0.01, I2 = 37%) compared upfront open PD.ConclusionsPatient outcomes are significantly compromised following unplanned intraoperative conversions of MIPD when compared to successfully completed MIPD and upfront open PD. These findings stress the need for objective evidence‐based guidelines for patient selection for MIPD.
Funder
National Health and Medical Research Council
PanKind, The Australian Pancreatic Cancer Foundation
Flinders Foundation
Flinders University
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献